Cut labeling rule proposed revision limits scope of controls to labeling likely to be used by consumers.
Executive Summary
FDA CUT LABELING CONTROLS LIMITED TO LABELING LIKELY TO BE READ BY CONSUMERS under a proposed rule published in the July 29 Federal Register. The proposed rule modifies regs published in August 1993 that "applied to all types of labeling including product inserts, multiunit containers packaged in individual containers and shipping containers," the Federal Register notice says. The rule enumerates control features required if cut labeling is used. Cut labeling, also known as gang-printed labeling, is "labeling derived from a sheet of material on which more than one item of labeling is printed." FDA found that because the various labeling pieces must be cut or separated and transported, "stacks of labeling of similar size, shape and color could easily be intermixed."
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth